Letrozole Tablets 2.5mg â€“ Targeted Hormone Therapy for Oncology

Letrozole Tablets 2.5mg are widely used anticancer hormone therapy. Identified by CAS 112809-51-5, they belong to aromatase inhibitors. Reduce estrogen production to slow cancer growth. Primarily used in breast cancer treatment. Manufactured under WHO-GMP standards for global compliance.

Letrozole Tablets are used in hormone receptor-positive breast cancer. Reduce estrogen levels by inhibiting aromatase enzyme. Effective in postmenopausal women. Also used in fertility treatments under supervision. Supported with COA, MSDS, and stability documentation. Globally accepted with strong clinical evidence.

Request Quote

Important Information

Letrozole Tablets are used in hormone receptor-positive breast cancer.
Reduce estrogen levels by inhibiting aromatase enzyme.
Effective in postmenopausal women.
Also used in fertility treatments under supervision.
Supported with COA, MSDS, and stability documentation.
Globally accepted with strong clinical evidence.

Storage

Store at 20Â°C to 25Â°C
Protect from moisture and sunlight
Keep in original packaging
Avoid excessive heat or humidity
Store in secure pharmaceutical conditions

Shelf Life

Shelf life typically 24 to 36 months
Stability tested under global standards
Packaging prevents degradation
Expiry clearly labeled

Dosage

General

Standard dose: 2.5mg once daily
Prescribed based on patient condition
Duration depends on treatment plan

Administration

Taken orally with or without food
Follow consistent daily schedule
Administer under medical supervision

Important

Regular monitoring required
Adherence ensures optimal effectiveness
Avoid self-medication

Manufacturing

Manufactured in WHO-GMP certified facilities
Advanced tablet compression systems
Controlled cleanroom environments
Strict quality assurance protocols
Comprehensive testing for purity and stability
Complies with USP, BP, and EP standards
Full regulatory documentation available

Precautions

Use only under medical supervision
Avoid during pregnancy and breastfeeding
Monitor bone density during long-term use
Use cautiously in liver conditions
Avoid alcohol and smoking

Side Effects

Hot flashes
Joint pain and stiffness
Fatigue
Nausea
Headache
Increased risk of osteoporosis

Expert View

Letrozole is a key hormone therapy in breast cancer treatment.
Widely used in both oncology and fertility treatments.
Cost-effective and clinically proven solution.
Trusted globally for consistent therapeutic outcomes.
Backed by strong regulatory and manufacturing standards.

Indications

Breast cancer treatment
Hormone receptor-positive cancer therapy
Fertility treatment (ovulation induction)
Oncology hormone therapy protocols

Maintenance

Follow prescribed dosage strictly
Monitor hormone levels regularly
Maintain bone health during long-term use
Avoid missed doses
Continue under medical supervision

Why Choose

WHO-GMP certified production
Reliable global supply chain
Competitive bulk pricing
Complete regulatory documentation
Consistent high-quality manufacturing

Frequently Asked Questions

Common product and supply questions.

What is the use of letrozole tablet?+

Letrozole Tablets are used to treat hormone receptor-positive breast cancer by reducing estrogen levels and slowing cancer cell growth in postmenopausal women.

What is the use of letrozole for pregnancy?+

Letrozole is used off-label to stimulate ovulation in women with fertility issues, improving chances of conception under medical supervision.

What happens after taking letrozole for 5 days?+

Ovulation is typically stimulated within a few days after a 5-day course, making it effective for fertility treatment when prescribed.

What are the side effects of taking letrozole?+

Common side effects include hot flashes, joint pain, fatigue, and nausea. Long-term use may impact bone density and requires monitoring.

What to avoid when taking letrozole?+

Avoid alcohol, smoking, and estrogen-based medications as they can reduce effectiveness and increase side effects.